Literature DB >> 18855025

Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation.

Lena Skoglund1, RoseMarie Brundin, Tommie Olofsson, Hannu Kalimo, Sofie Ingvast, Elin S Blom, Vilmantas Giedraitis, Martin Ingelsson, Lars Lannfelt, Hans Basun, Anna Glaser.   

Abstract

Mutations in the progranulin (PGRN) gene have recently been identified in families with frontotemporal lobar degeneration and ubiquitin-positive brain inclusions linked to chromosome 17q21. We have previously described a Swedish family displaying frontotemporal dementia with rapid progression and linkage to chromosome 17q21. In this study, we performed an extended clinical and neuropathological investigation of affected members of the family and a genetic analysis of the PGRN gene. There was a large variation of the initial presenting symptoms in this family, but common clinical features were non-fluent aphasia and loss of spontaneous speech as well as personality and behavioural changes. Mean age at onset was 54 years with disease duration of close to 4 years. Neuropathological examination revealed frontotemporal neurodegeneration with ubiquitin and TAR DNA binding protein-43 immunoreactive intraneuronal inclusions. Mutation screening of the PGRN gene identified a 1 bp deletion in exon 1 causing a frameshift of the coding sequence and introducing a premature termination codon in exon 2 (Gly35GlufsX19). Analysis of PGRN messenger RNA (mRNA) levels revealed a considerable decrease in lymphoblasts from mutation carriers and fragment size separation, and sequence analysis confirmed that the mutated mRNA allele was almost absent in these samples. In conclusion, the PGRN Gly35fs mutation causes frontotemporal dementia with variable clinical presentation in a large Swedish family, most likely through nonsense-mediated decay of mutant PGRN mRNA and resulting haploinsufficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18855025     DOI: 10.1007/s10048-008-0155-z

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  35 in total

1.  Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22.

Authors:  S M Rosso; W Kamphorst; B de Graaf; R Willemsen; R Ravid; M F Niermeijer; M G Spillantini; P Heutink; J C van Swieten
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

2.  Frontotemporal lobar degeneration and ubiquitin immunohistochemistry.

Authors:  K A Josephs; J L Holton; M N Rossor; A K Godbolt; T Ozawa; K Strand; N Khan; S Al-Sarraj; T Revesz
Journal:  Neuropathol Appl Neurobiol       Date:  2004-08       Impact factor: 8.090

3.  Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration.

Authors:  Anne M Lipton; Charles L White; Eileen H Bigio
Journal:  Acta Neuropathol       Date:  2004-09-04       Impact factor: 17.088

Review 4.  Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges.

Authors:  Holly A Kuzmiak; Lynne E Maquat
Journal:  Trends Mol Med       Date:  2006-06-16       Impact factor: 11.951

5.  Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia.

Authors:  H Basun; O Almkvist; K Axelman; A Brun; T A Campbell; J Collinge; C Forsell; S Froelich; L O Wahlund; L Wetterberg; L Lannfelt
Journal:  Arch Neurol       Date:  1997-05

6.  A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology.

Authors:  J B Leverenz; C E Yu; T J Montine; E Steinbart; L M Bekris; C Zabetian; L K Kwong; V M-Y Lee; G D Schellenberg; T D Bird
Journal:  Brain       Date:  2007-04-17       Impact factor: 13.501

7.  Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions.

Authors:  A Kertesz; T Kawarai; E Rogaeva; P St George-Hyslop; P Poorkaj; T D Bird; D G Munoz
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

Review 8.  Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis.

Authors:  Zhiheng He; Andrew Bateman
Journal:  J Mol Med (Berl)       Date:  2003-08-19       Impact factor: 4.599

9.  Familial aggregation in frontotemporal dementia.

Authors:  M Stevens; C M van Duijn; W Kamphorst; P de Knijff; P Heutink; W A van Gool; P Scheltens; R Ravid; B A Oostra; M F Niermeijer; J C van Swieten
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

10.  Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival.

Authors:  Philip Van Damme; Annelies Van Hoecke; Diether Lambrechts; Peter Vanacker; Elke Bogaert; John van Swieten; Peter Carmeliet; Ludo Van Den Bosch; Wim Robberecht
Journal:  J Cell Biol       Date:  2008-03-31       Impact factor: 10.539

View more
  8 in total

1.  Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity.

Authors:  Wangchao Xu; Puhua Bao; Xin Jiang; Haifang Wang; Meiling Qin; Ruiqi Wang; Tao Wang; Yi Yang; Ileana Lorenzini; Lujian Liao; Rita Sattler; Jin Xu
Journal:  Brain       Date:  2019-05-01       Impact factor: 13.501

2.  Progranulin-associated PiB-negative logopenic primary progressive aphasia.

Authors:  Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Prashanthi Vemuri; Matthew L Senjem; Ralph B Perkerson; Matthew C Baker; Val Lowe; Clifford R Jack; Rosa Rademakers; Jennifer L Whitwell
Journal:  J Neurol       Date:  2014-01-22       Impact factor: 4.849

3.  Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN).

Authors:  Tomasz Gabryelewicz; Mario Masellis; Mariusz Berdynski; Juan M Bilbao; Ekaterina Rogaeva; Peter St George-Hyslop; Anna Barczak; Krzysztof Czyzewski; Maria Barcikowska; Zbigniew Wszolek; Sandra E Black; Cezary Zekanowski
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  A common biological mechanism in cancer and Alzheimer's disease?

Authors:  M I Behrens; C Lendon; C M Roe
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

5.  Genetic screen in a large series of patients with primary progressive aphasia.

Authors:  Eliana Marisa Ramos; Deepika Reddy Dokuru; Victoria Van Berlo; Kevin Wojta; Qing Wang; Alden Y Huang; Zachary A Miller; Anna M Karydas; Eileen H Bigio; Emily Rogalski; Sandra Weintraub; Benjamin Rader; Bruce L Miller; Maria Luisa Gorno-Tempini; Marek-Marsel Mesulam; Giovanni Coppola
Journal:  Alzheimers Dement       Date:  2019-01-25       Impact factor: 21.566

6.  FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.

Authors:  Robert Rusina; Gabor G Kovacs; Jindřich Fiala; Jakub Hort; Petr Ridzoň; Iva Holmerová; Thomas Ströbel; Radoslav Matěj
Journal:  BMC Neurol       Date:  2011-05-10       Impact factor: 2.474

Review 7.  A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.

Authors:  Takashi Hosaka; Kazuhiro Ishii; Takeshi Miura; Naomi Mezaki; Kensaku Kasuga; Takeshi Ikeuchi; Akira Tamaoka
Journal:  BMC Neurol       Date:  2017-09-15       Impact factor: 2.474

8.  Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia.

Authors:  Karthick Natarajan; Jesper Eisfeldt; Maria Hammond; José Miguel Laffita-Mesa; Kalicharan Patra; Behzad Khoshnood; Linn Öijerstedt; Caroline Graff
Journal:  Acta Neuropathol Commun       Date:  2021-08-03       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.